MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study

BACKGROUND: A substantial impediment to progress in trials of new therapies in neuromuscular disorders is the absence of responsive outcome measures that correlate with patient functional deficits and are sensitive to early disease processes. Irrespective of the primary molecular defect, neuromuscul...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Lancet Neurol
Egile Nagusiak: Morrow, Jasper M, Sinclair, Christopher D J, Fischmann, Arne, Machado, Pedro M, Reilly, Mary M, Yousry, Tarek A, Thornton, John S, Hanna, Michael G
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lancet Pub. Group 2016
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4672173/
https://ncbi.nlm.nih.gov/pubmed/26549782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(15)00242-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak